PARIS, Nov. 13 /PRNewswire/ -- Cegedim Strategic Data, leading provider of Pharmaceutical Market Research has completed its acquisition of 3ES, a CRO (Contract Research Organisation) member of the AFCRO (French Association of CROs), specializing in Clinical Studies and post-AMM studies, notably through online tools.
3ES was founded in 1998 to meet the needs of its partners in areas such as organization, data management, and analysis of medical data, thus providing multidisciplinary expertise in the medical research field.
3ES has developed in-house its software INES, which is dedicated to the management of clinical and online studies, in order to leverage new technologies in the domain of Clinical Research. 3ES benefits from an established experience in the management of various studies with CRF (Case Report Form) either online or on paper, and on a national and international basis.
The 3ES team (15 people) will join CSD's international Pharmaco- Epidemiological team based in CSD's Headquarters in Boulogne (France). CSD's Pharmaco-Epidemiological Research has been established in the UK and France for over 10 years, and has extended its activities into Italy, Germany, Belgium and the USA in June 2007. Both of these entities will form CSD's Medical Research Service, the primary objective being to broaden the scope of CSD's medical studies both in France and internationally.
According to Bruno Sarfati, president of Cegedim Strategic Data, "The merging of these two complementary teams will allow CSD to reinforce its global offer in Medical Research; by covering hospitals and, more particularly, oncology."
CSD is equipped to respond to pharmaceutical companies Medical Research needs, through its expertise, renowned data sources, tools and its organization:
Overall, CSD's International Medical Research Service will benefit from the combination of two multidisciplinary teams dedicated to pharmaco- epidemiological, economic and clinical studies, to develop an integrated offer.
About 3ES:
Contrary to the majority of CROs or SSIIs, 3ES has associated the complementary expertise of medical, statistic, and software engineering. Founded in 1998 by doctors specialized in Public Health, 3ES provides multidisciplinary expertise in the medical research field. 3ES has developed their in-house software for managing online studies via Internet, and has received the ANVAR label for "innovating business".
To learn more, please see our website: www.3es.fr
About Cegedim Strategic Data:
CSD is a leading Market Research company dedicated to the healthcare industry and operating in more than 58 countries.
With over 35 years experience in the Pharmaceutical industry CSD (previously CAM, Thales, Zoom and Decisions Research) offers a comprehensive range of market research services and solutions to meet the needs of its customers, which include more than 50 global and 500 local Pharmaceutical companies. The capability to integrate primary market research with audited promotional data from PCPs, Specialists and Pharmacists, and merge it with longitudinal patient level data is what sets the company apart from its competition.
To learn more, please see our website: www.cegedimstrategicdata.com
About CEGEDIM:
CEGEDIM has been developing exclusive databases and high value added software solutions since 1969.
Established as the world's leading CRM provider for the life sciences industry with its Cegedim Dendrite business unit, CEGEDIM provides the world's largest pharmaceutical companies with vital support for successful Customer Relationship Management (CRM). Its Cegedim Strategic Data and Cegedim Customer Information activities are also dedicated to pharmaceutical companies and help them improve sales & marketing effectiveness thanks to the Group's strategic databases focused on the world drug market.
This expertise falls into the "Healthcare and strategic data" division of the CEGEDIM Group, which comprises the services specifically designed for pharmaceutical companies cited above and specific solutions dedicated to healthcare professionals (notably physicians and pharmacists in Europe) and health insurance providers.
The "Technologies and services" division capitalizes on the Group's technical skills in order to provide specific solutions to clients of various sectors, essentially in France.
CEGEDIM generated turnover of euro 541 million in 2006. Including Dendrite, the 2006 cumulated revenue would amount to euro 877 million for a workforce of 7,500 and operations in more than 80 countries.
To learn more, please see our website: www.cegedim.commilena.brankova@cegedim.comaude.labrune@cegedim.fr
CONTACT: Milena Brankova, Regional Director - Americas, Cegedim Strategic
Data, +1-201-871-5913, milena.brankova@cegedim.com, or Aude Labrune, Media
Relations, CEGEDIM, + 33 1 49 09 86 15, aude.labrune@cegedim.fr
Web site: http://www.cegedim.com/
http://www.cegedimstrategicdata.com//
